Soleno Therapeutics Overview

Soleno Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SLNO.

Quarterly EBIT

$31.28M

As of Mar 31, 2026

Annual EBIT (TTM)

$100.06M

↑ 164.88% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin